Logo of jcellbiolHomeThe Rockefeller University PressThis articleEditorsContactInstructions for AuthorsThis issue
J Cell Biol. 2008 Jun 30; 181(7): 1095–1105.
PMCID: PMC2442213

Role of Sec61p in the ER-associated degradation of short-lived transmembrane proteins


Misfolded proteins in the endoplasmic reticulum (ER) are identified and degraded by the ER-associated degradation pathway (ERAD), a component of ER quality control. In ERAD, misfolded proteins are removed from the ER by retrotranslocation into the cytosol where they are degraded by the ubiquitin–proteasome system. The identity of the specific protein components responsible for retrotranslocation remains controversial, with the potential candidates being Sec61p, Der1p, and Doa10. We show that the cytoplasmic N-terminal domain of a short-lived transmembrane ERAD substrate is exposed to the lumen of the ER during the degradation process. The addition of N-linked glycan to the N terminus of the substrate is prevented by mutation of a specific cysteine residue of Sec61p, as well as a specific cysteine residue of the substrate protein. We show that the substrate protein forms a disulfide-linked complex to Sec61p, suggesting that at least part of the retrotranslocation process involves Sec61p.


The ER provides an environment conducive for the folding and assembly of newly synthesized secretory proteins. To prevent the premature exit of improperly folded proteins from the ER, cells have evolved quality control mechanisms to actively monitor the folding state of proteins (Brodsky and McCracken, 1999; Ellgaard and Helenius, 2003). Proteins that irreversibly misfold are recognized by this quality control system and targeted for destruction through a process termed ER-associated degradation (ERAD; Hampton, 2002). Although initial studies of ERAD implied the action of unidentified ER-localized proteases (Finger et al., 1993), subsequent work clearly defined roles for the cytoplasmically localized enzymes of the ubiquitin pathway and the 26S proteasome, providing the first indication that misfolded proteins must be retrotranslocated back across the membrane of the ER (Jensen et al., 1995; Ward et al., 1995). From a mechanistic standpoint, these results established the need for an ER-localized protein-conducting channel to direct the flow of misfolded protein export from the ER.

Circumstantial evidence suggested that Sec61p, the main component of the protein-conducting channel for translocation into the ER, participates in retrotranslocation from the ER (Wiertz et al., 1996; Pilon et al., 1997; Plemper et al. 1997, 1998). In mammalian cells, Sec61α can be coimmunoprecipitated with class I heavy chains that are targeted for ERAD by the human cytomegalovirus-encoded glycoprotein US2 (Wiertz et al., 1996). Subsequently, genetic and biochemical analysis of Sec61p mutants uncovered alleles more prone to defects in protein retrotranslocation than translocation (Pilon et al., 1997). Certain ERAD substrates are stabilized in a partially translocation-defective mutant, sec61-2 (Plemper et al., 1997, 1998). In an independent approach, Schmitz et al. (2000) showed that blocking Sec61 channels with translation-arrested ribosomes prevented exit of cholera toxin from the ER. However, when the crystallographic structure of SecY/E, an archaeal orthologue of Sec61p, revealed a strict upper size limit for the pore diameter, it was difficult to conceive how such a small pore could accommodate the larger retrotranslocation substrates (Tirosh et al., 2003; Van den Berg et al., 2004). Nonetheless, for certain proteins that are subject to ERAD before the completion of translocation, new evidence suggests a direct participation of Sec61p in the ERAD process (Oyadomari et al., 2006). For the majority of proteins subject to ERAD after membrane assembly, the evidence favors one or more distinct retrotranslocation channels.

Another candidate channel protein, Derlin-1, was identified by virtue of its association with the human cytomegalovirus-encoded glycoprotein US11 in the process of retrotranslocation and degradation of class I heavy chains (Lilley and Ploegh, 2004; Ye et al., 2004). The interaction of Derlin-1 with glycosylated class I heavy chains before retrotranslocation and its subsequent association with deglycosylated heavy chains when cells are treated with proteasome inhibitors suggest that it is positioned to interact with substrates before and immediately after they are retrotranslocated (Lilley and Ploegh, 2005). The role of the yeast Derlin-1 homologue Der1p in ERAD is poorly defined but is known to be required for the efficient degradation of misfolded luminal ER proteins (Knop et al., 1996; Hitt and Wolf, 2004). However, numerous ERAD substrates are degraded independent of Der1p (Hill and Cooper, 2000; Vashist and Ng, 2004). A subset of these Der1p-independent substrates is also independent of Sec61p but requires Doa10, an ER-localized E3 ubiquitin ligase. Thus, Doa10 may represent a distinct retrotranslocation channel in the ER (Kreft et al., 2006).

In this paper, we describe our discovery and characterization of a disulfide-linked intermediate complex formed between a short-lived transmembrane ERAD substrate and Sec61p. This complex may accomplish at least an initial stage in the retrotranslocation of unstable membrane proteins.


Cysteine mutants of Sec61p are protein retrotranslocation proficient

To test for defects in the ER export of misfolded membrane proteins, we followed the degradation kinetics of the short-lived transmembrane substrate Deg1:Sec62ProtA. The Deg1 sequence appended to the N terminus of Sec62 (Deshaies and Schekman, 1989) diverts the hybrid protein to the ERAD pathway (Mayer et al., 1998). In wild-type cells, Deg1:Sec62ProtA was rapidly degraded with t1/2 of ∼13 min (Fig. 1, A and B). Previously, we reported the effect of a substitution at cysteine 150 of the translocation channel (sec61–32; C15OY) on the ERAD of an unglycosylated form of α-factor (αf) precursor (Pilon et al., 1997). To explore the role of each of the cysteine residues of Sec61p in the ERAD of Deg1:Sec62ProtA, we created strains in which one or more of these residues was mutated on a CEN plasmid as the sole copy of SEC61. The rate of substrate degradation was accelerated nearly twofold in a strain harboring Sec61p C373I (t1/2 = 7–8 min; Fig. 1, A and B), whereas Sec61p C121G or C150V had no influence on the degradation rate (t1/2 = 13 min; Fig. 1, A and B). As a control, we also monitored the rate of substrate degradation in a yeast strain harboring the retrotranslocation (and translocation)-defective sec61-2 allele (Plemper et al., 1997). In this background the rate of substrate degradation was not altered, which is consistent with previous reports on the degradation of a misfolded membrane substrate containing a misfolded cytosolic domain (Ste6*; Huyer et al., 2004; see alsoDiscussion). In wild-type and mutant strains, except C373I, we observed two electrophoretically distinct species of substrate. The more rapidly migrating species predominated in C373I (Fig. 1 A).

Figure 1.
Sec61p cysteine mutants are proficient for ER protein export. (A) Wild-type and Sec61p mutant cells expressing the transmembrane ERAD substrate Deg1:Sec62ProtA were pulse labeled for 5 min and chased for the indicated times. Deg1:Sec62ProtA was immunoprecipitated, ...

We evaluated the degradation of another unstable ERAD substrate, CPY*, in the wild-type and Sec61p cysteine mutant strains. In wild-type cells, CPY* was degraded with a t1/2 of ∼25 min (Fig. 1, C and D). Mutations at position 121 or 150 of Sec61p retained wild-type degradation kinetics, whereas mutation of residue 373 resulted in a slight, but reproducible, stabilization of CPY* (t1/2 = 28–30 min; Fig. 1, C and D). In contrast, CPY* degradation was delayed around twofold in the sec61-2 mutant, which is consistent with previous reports for this mutant (Plemper et al., 1997). In all experiments, we observed a single electrophoretic species of CPY* unlike the behavior of Deg1:Sec62ProtA.

Deg1:Sec62ProtA is N glycosylated

The effect of Sec61p C373I on the production of one of two electrophoretic species of Deg1:Sec62ProtA led us to consider the possibility that a covalent modification accompanies the ERAD of this substrate. Although the N and C termini of Sec62p are exposed to the cytosol, the N-terminal Deg signal may influence the disposition of Sec62 during ERAD. Thus, one possibility was that cryptic N-glycosylation sites in the N terminus of Sec62p may become exposed to the ER lumen during ERAD. We found that Deg1:Sec62ProtA was sensitive to endoglycosidase H, which is consistent with a previous report for Deg1:Sec62ProtA (Fig. 2 A; Kim et al., 2006).

Figure 2.
Deg1:Sec62ProtA is modified by N-linked glycosylation. (A, left) Schematic representation of Deg1:Sec62ProtA and its presumed membrane topology. The relative positions of the two cryptic N-glycan acceptor sites (Asn90 and Asn153) are depicted. (A, middle) ...

The primary sequence of Deg1:Sec62ProtA possesses two consensus N-glycosylation sites, with the reactive asparagines positioned at residues 90 and 153 (Fig. 2 A). Site-directed mutagenesis of Asn90 resulted in no change in the two Deg-Sec62 species (Fig. 2 B, compare lanes 1 and 2). In contrast, the lower mobility glycosylated form of Deg1:Sec62ProtA disappeared in an Asn153 mutant (Fig. 2 B, compare lanes 1 and 5), indicating that Asn153, but not Asn90, was N glycosylated.

Sec62 is a double pass unglycosylated transmembrane protein with the N and C termini facing the cytosol (Deshaies and Schekman, 1989). Conceivably, the attachment of Deg1 to the N terminus and ProtA to the C terminus altered the topology of the hybrid protein. However, we found that the Deg1:Sec62ProtA hybrid complemented a sec62 mutant for growth (unpublished data). In addition, we were unable to detect substrate protein with antibodies directed against either the N- or C-terminal tail of the hybrid protein after treatment of intact ER membranes with protease (Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb.200804053/DC1), which ruled out a potential heterogeneous topological population of the hybrid. Thus, glycosylation of Asn153 suggested that the N terminus became exposed to the ER lumen at some point during the course of synthesis or degradation of the hybrid protein. In an attempt to further define regions of the N- or C-terminal tails that were exposed to the lumen, we introduced additional acceptor sequences throughout the polypeptide chain and evaluated the glycosylation state of these mutants. The introduction of an additional acceptor site within 30 aa of Asn153 led to the production of a doubly glycosylated substrate (Fig. 2 B, lanes 4 and 6). However, addition of sites at positions further removed from this site, as well as multiple sites within the C-terminal tail, maintained a singly glycosylated profile characteristic of the wild-type substrate (Fig. 2 B, lanes 3 and 7–10). These results indicate that a minimal region of ∼50 aa within the N-terminal cytosolic tail becomes exposed to the lumen of the ER.

Cysteine mutants of Sec61p are protein translocation proficient

A protein translocation defect could account for the effect of the Sec61p C373I mutant on ERAD of Deg1:Sec62:ProtA. We examined the protein import functionality of the Sec61p cysteine mutants by pulse labeling and immunoprecipitation of model secretory proteins (Fig. 3; Pilon et al., 1997, 1998).

Figure 3.
Sec61p cysteine mutants are proficient for ER protein import. Wild-type and Sec61p mutant cells were pulse labeled at 30°C for 15 min and model secretory proteins were immunoprecipitated from detergent-solubilized lysates. The immunoprecipitated ...

The yeast mating pheromone αf is synthesized in the cytosol as a prepro precursor form (ppαf). Upon translocation into the ER, ppαf becomes signal cleaved (pαf) and modified by the addition of three N-linked glycans (3gpαf). In Sec61p wild-type and cysteine mutant cells, 3gpαf was not observed because transport and proteolytic maturation were too rapid (Fig. 3, top, lanes 1, 7, 9, and 11). Pretreatment of cells with tunicamycin, an inhibitor of N-linked glycosylation, led to the accumulation of signal-cleaved pαf in the ER (Fig. 3, top, lanes 2, 4, 8, 10, and 12). The translocation mutants sec61-2 and sec61-32 accumulated ppαF, whereas C121G, C150V, and C373I did not (Fig. 3, top, lanes 5 and 6). The difference between sec61-32 (C150Y) and C150V may be attributable to the nature of the substitution. C150Y also produced a cold-sensitive defect, whereas C150V did not. However, other more substantial changes at C121 and C373 led to growth defects (unpublished data).

The vacuolar protease carboxypeptidase Y (CPY) is signal cleaved upon translocation into the ER (proCPY) and modified by N-linked glycosylation (p1 CPY). During its transit through the Golgi complex, outer chain mannose residues are added (p2CPY). Upon arrival at the vacuole, p2CPY is proteolytically cleaved to produce the mature form (mCPY). The p1, p2, and mature forms of CPY were detected in wild-type and C121G, C150V, and C373I mutants (Fig. 3, middle, lanes 1, 7, 9, and 11). Thus, these mutations did not affect proCPY translocation, whereas sec61-32 did (Fig. 3, lane 5). The precursor form of the luminal chaperone Kar2p was efficiently translocated and processed to the mature form in Sec61p wild-type and C121G, C150V, and C373I mutant backgrounds (Fig. 3, bottom, lanes 1, 7, 9, and 11).

Glycosylation of Deg1:Sec62ProtA occurs during degradation

We considered the possibility that the Deg1 sequence served as a surrogate signal peptide causing the N terminus of Sec62 to be translocated and exposed to the oligosaccharyltransferase in the ER lumen. To test this, we constructed a Deg1:Sec62 deletion hybrid containing residues of Sec62 up to the first transmembrane segment (Deg1:Sec62 1–149). Cells were radiolabeled in the absence and presence of tunicamycin and flag-tagged hybrid proteins were immunoprecipitated from lysates. Unlike the Deg1:Sec62 full-length hybrid, Deg1:Sec62 1–149 accumulated in an unglycosylated form (Fig. 2 C). As a control, we fused the prepro region of αf, which contains a signal peptide and a pro peptide with three N-glycosylation sites, to the N-terminal cytoplasmic tail of Sec62 (proFactor:Sec62 1–149). This hybrid produced multiple glycosylated tunicamycin-sensitive species that accumulated in cells (lysate) and secreted glycosylated forms, which were sensitive to Endo H, into the culture fluid (supernatant; Fig. 2 C). We conclude that the N terminus of Sec62 can be translocated and glycosylated as directed by a standard signal sequence but that the Deg1 sequence does not act as a typical secretory signal.

The lack of a protein translocation defect for the Sec61p cysteine 373 mutant suggested that glycosylation of Deg1:Sec62ProtA may occur during ERAD. We next measured the rate of formation of the glycosylated substrate in backgrounds that stabilized substrate yet did not affect its import. Thus, if glycosylation occurred during the degradation process, the formation of the glycosylated species may be delayed in mutants defective in ERAD. After a short pulse label of 2 min, the glycosylated and unglycosylated forms were labeled in roughly equal amounts in wild-type cells (glycosylated/unglycosylated = 1; Fig. 4, A and B). This ratio increased with labeling time and approached a ratio of four at 8 min of pulse label (Fig. 4, A and B). The ratio was decreased in a mutant lacking the E2 ubiquitin-conjugating enzyme, Ubc7p, with ratios of 0.5 and 2.7 at 2 and 8 min, respectively (Fig. 4, A and B). Although the delay was significant, it was clearly not complete. This observation is likely caused by the independence of ubiquitination for the initial stages of retrotranslocation (Flierman et al., 2003). We then introduced site-specific mutations in the Deg1 signal itself in an effort to disrupt an early step in the retrotranslocation event. A systematic study of the Deg1 signal localized its degradation determinant to a relatively short peptide segment spanning residues 13–32. We selected mutations that significantly stabilize a Deg1:βgal fusion protein (Johnson et al., 1998; t1/2s for deg1 mutant hybrids: F18S ≈ 40 min, F18S/l29H ≈ 120 min, Δ13–32 ≥ 200 min [unpublished data]). As shown in Fig. 4 (C and D), substitution of serine for phenylalanine at position 18 of the signal resulted in a pronounced delay in the formation of glycosylated substrate (ratios of 0.2 and 1.5 at 2 and 8 min, respectively). The rate was further reduced in the double mutant, F18S/L29H, with ratios of 0.1 and 0.8, respectively (Fig. 4, C and D). In the most extreme case, deletion of the entire Deg1 determinant prevented glycosylation of the substrate entirely (Δ13–32, ratios at 2 and 8 min = 0; Fig. 4, C and D). Thus, the delay in the appearance of glycosylated substrate in Deg1 mutants supports the notion that ER penetration of the N terminus of Deg1:Sec62ProtA occurs during degradation.

Figure 4.
Glycosylation of Deg1:Sec62ProtA occurs during degradation. (A) Wild-type and Δubc7 cells expressing Deg1:Sec62ProtA were pulse-labeled for 2, 4, 6, or 8 min. Deg1:Sec62ProtA was immunoprecipitated, resolved on SDS-PAGE, and visualized by audioradiography. ...

Glycosylation of Deg1:Sec62ProtA is not required for its recognition or targeting

The ERAD of soluble glycoproteins requires glycan trimming and recognition by lectin-like receptors (Liu et al., 1999; Spear and Ng, 2005). We asked if the addition of N-linked glycan to Deg1:Sec62ProtA played a role in its degradation. Two independent lines of evidence suggested that this was not the case. Pulse-chase analysis of the mutant substrate protein carrying a disruption of the acceptor site asparagine (Asn153; Fig. 2 C) revealed degradation rates identical to those of its wild-type counterpart (t1/2 = 13 min; Fig. 2, D and E). Furthermore, the degradation rate of wild-type substrate was independent of the lectin-like receptors Htm1p/Mnl1p and Yos9p (Jakob et al., 2001; Kim et al., 2005; unpublished data). We conclude that the addition of oligosaccharide to Deg1:Sec62ProtA plays no mechanistic role in the ERAD of this substrate. Rather, it appears as a byproduct of the process by which the substrate is degraded.

A single cysteine residue in Deg1:Sec62ProtA is also required for glycosylation

We next considered the possibility that cysteine 373 of Sec61p may form a transient disulfide bond to Deg1:Sec62ProtA to promote or stabilize the insertion of the N-terminal domain of the hybrid protein in the lumen of the ER. The primary sequence of Deg1:Sec62ProtA contains five cysteine residues, three of which (Cys33, Cys34, and Cys200) are localized within the N-terminal cytosolic tail, one (Cys255) within transmembrane domain one, and the last (Cys315) to the C-terminal cytosolic tail. Cysteine to serine mutation of residues 33, 34, 255, or 315 had no effect on the formation of the glycosylated substrate species (Fig. 5 A). However, mutagenesis of cysteine 200 produced an unglycosylated form of the hybrid protein (Fig. 5 A). The inability of this substrate cysteine mutant to become glycosylated resembled the effect of Sec61p C373I on wild-type hybrid protein (compare Fig. 1 A to Fig. 5 A). Thus, a disulfide bond may form between the hybrid protein and the translocation channel (or with other proteins) as an intermediate in the ERAD process. The formation of this intermediate may promote the formation of the glycosylated hybrid but impede the ERAD process. ERAD was accelerated in the C373I Sec61p mutant (Fig. 1, A and B) and in the C200S mutant Deg1 hybrid protein (t1/2 = 8 min for C200S vs. t1/2 = 13 min for wild type; Fig. 5, B and C). Reduction of a disulfide-linked intermediate may become rate limiting for ERAD of this substrate.

Figure 5.
Glycosylation of Deg1:Sec62ProtA is dependent on a cysteine residue within the substrate protein. (A) Wild-type and cysteine mutant alleles of Deg1:Sec62ProtA were pulse labeled for 5 min. Deg1:Sec62ProtA was immunoprecipitated, resolved by SDS-PAGE, ...

Isolation of a disulfide-bonded substrate-Sec61p intermediate

To obtain direct evidence for the presence of a disulfide complex, we used a two-dimensional nonreducing/reducing electrophoresis strategy. To limit nonspecific disulfide-bonded species, we created a version of the substrate protein that contained cysteine-to-serine substitutions at the four residues not required for formation of the glycosylated substrate (Cys33, 34, 255, and 315; Fig. 5 A). In addition, the Protein A tag was removed to prevent cross-reactivity of substrate with antibodies directed against Sec61p. These modifications were without phenotypic consequence, as the modified substrate retained wild-type glycosylation and degradation kinetics (unpublished data).

Two-dimensional gels probed for substrate revealed three species. One (spot A) represented the monomeric substrate protein because it migrated at the predicted molecular weight for monomer in both dimensions (Fig. 6 A, spot A, molecular mass 41 kD). Another (spot C) migrated in the nonreducing dimension at a position of roughly 100 kD and likely represents a disulfide-bonded homodimer of the substrate protein (see subsequent paragraph and Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200804053/DC1). This species migrated at a position consistent with monomer hybrid protein in the reducing second dimension of electrophoresis (Fig. 6 A, spot C). Moreover, this disulfide complex persists in the Sec61p C373S mutant (Fig. 6 A, spot C). A final species (spot B) migrated at a position consistent with an apparent molecular mass of ∼70 kD (Fig. 5 A, spot B). The size of this complex in the nonreducing dimension conformed to the range of molecular masses expected for a Sec61p-Deg1:Sec62 disulfide complex (35 kD + 41 kD = 76-kD complex). Furthermore, this species was not detected in a strain harboring the Sec61p C373S mutation (Fig. 6 A, compare wild type and C373S). We confirmed the presence of Sec61p within the 70-kD complex by probing the two-dimensional blots with antibodies directed against a myc epitope located at the extreme C terminus of Sec61p. Two species were evident: one represented monomeric Sec61p, which migrated at a position of roughly 35 kD in both dimensions (Fig. 6 B, spot A), and another that migrated at a position corresponding to an ∼70-kD species in the nonreducing dimension, which collapsed to 35 kD upon reduction (Fig. 6 B, spot B).

Figure 6.
Two dimensional nonreducing/reducing electrophoresis. (A) Membranes from wild-type or Sec61p C373S cells expressing ΔCys4:Deg1:Sec62ΔProtA were prepared for two-dimensional electrophoresis as described in Materials and methods. After electrophoresis, ...

A Sec61p species that migrated in the two-dimensional gels at a position similar to Spot B persisted in the C373S mutant background (Fig. 6 B). This form was observed in membranes from a strain in which all three Sec61p cysteine residues were mutated (unpublished data). This species may represent a stable nondisulfide dimer of Sec61p that resists complete denaturation at the high protein concentration used in sample preparation for this analysis. Nevertheless, we reproducibly observed a sixfold difference in the abundance of Spot B in wild-type versus the C373S Sec61p mutant background (wild type/C373S = 5.8 ± 0.45; see Materials and methods). We conclude that the majority of Spot B is a disulfide-bonded heterocomplex between residue 373 of Sec61p and residue 200 of Deg1:Sec62.

To determine if the Sec61p–Deg1:Sec62 disulfide complex forms as a result of the degradation of Deg1:Sec62ProtA, we subjected the deg1 determinant deletion mutant Δ13–32 to the two-dimensional analysis. Deletion of the deg1 degradation signal confers to the hybrid protein stability and an inability to become modified with glycan (Fig. 4, C and D), presumably because it can no longer enter the ERAD pathway. When this mutant is analyzed by two-dimensional nonreducing/reducing electrophoresis only monomeric substrate protein is observed (Fig. S2, spot A). The absence of the Sec61p–Deg1:Sec62 disulfide complex, spot B, confirms that the substrate protein must be degradation competent to form a disulfide complex with Sec61. Disappearance of the higher molecular mass complex, spot C, suggests that this spot represents a disulfide-bonded homodimer of the substrate protein, which is consistent with removal of a large segment of the region shown to mediate MATα2 homodimerization (α2A residues 18–43; Ho et al., 2002).


Improperly folded secretory proteins are recognized and targeted for degradation by a quality control system in the ER. Misfolded substrates are degraded by the cytosolic 26S proteasome. Hence, they must first be retrotranslocated back across the membrane of the ER. Despite significant progress in understanding the events of misfolded protein recognition, targeting, and degradation, the retrotranslocation process remains poorly defined. A significant obstacle to further defining this event is the observation that different substrate molecules display distinct genetic and biochemical requirements for their degradation.

Our discovery of a disulfide intermediate complex between Sec61p and the short-lived transmembrane ERAD substrate Deg1:Sec62ProtA provides direct evidence for the participation of Sec61p in the retrotranslocation process, possibly serving as a retrotranslocation channel. In support of this view is the recent characterization of proteasome binding sites within Sec61p (Ng et al., 2007) and the ER stress-induced induction of subunits of the TRAP complex (Nagasawa et al., 2007). Although we cannot rule out the action of alternative channels in the ERAD of Deg1:Sec62ProtA, it is degraded independently of Der1p and its yeast orthologue Dfm1p (Hitt and Wolf, 2004; unpublished data). In contrast, yeast cells lacking the E3 ubiquitin ligase Doa10p stabilize the hybrid twofold (unpublished data). However, because Doa10p functions in the degradation of ER-associated and cytosolic substrates, we cannot discriminate roles in the recognition of the deg signal or as an ERAD channel (Swanson et al., 2001).

The byproduct of disulfide complex formation is the addition of oligosaccharide to a short segment of the N-terminal tail of Deg1:Sec62ProtA. This tail is otherwise cytoplasmically localized, indicating that during the retrotranslocation of membrane substrates, cytosolic loops and/or tails pass through the lumen of the ER. The formation of a glycoprotein intermediate may require the action of Sec61p and may become apparent only when substrate extraction is delayed by formation of the disulfide complex. Given the small number of misfolded transmembrane substrates available for study and the specific requirements for an appropriately placed cysteine residue and glycosylation acceptor site, this unusual intermediate may have escaped detection in other ERAD substrates. As an example, a recent study on the degradation of a Deg1:Vma12ProtA hybrid protein failed to reveal a glycoprotein intermediate (Ravid et al., 2006). Vma12p is similar in size and membrane topology to Sec62p (Jackson and Stevens, 1997), and the Deg-Vma12 hybrid is degraded with a half-life of 7 min, which is identical to the degradation rate of the Deg-Sec62 cysteine mutant hybrid (Fig. 1, A and B; and Fig. 5, B and C). Degradation of Deg-Vma12 proceeds without apparent covalent modification, perhaps because the coding sequence contains no glycosylation acceptor sites and the only cysteine present in the N-terminal cytosolic domain is 75 residues away from the first transmembrane domain. In contrast, the Sec62 coding sequence contains two potential glycosylation sites (N90 and N153; Fig. 2), and the cysteine involved in disulfide bonding to Sec61p is only 40 residues removed from the first transmembrane domain.

How are cytoplasmic regions of misfolded transmembrane proteins reoriented during the retrotranslocation process so that they become exposed to the lumen of the ER? Our results suggest that the Deg signal recruits the N-terminal domain of the hybrid protein, possibly through the first transmembrane anchor domain, into the Sec61p channel where at least a portion of the polar N terminus is imported into the ER lumen (Fig. 7, A [II–IV] or B [III-IV]). This event may be preceded by the retrotranslocation of the C-terminal domain of the hybrid, as depicted in Fig. 7 B (I–III), or by the prior action of a distinct channel.

Figure 7.
Models for disulfide complex formation and substrate glycosylation. (A) A model depicting a role for Sec61p in the initial state of Deg1 translocation into the ER. In this model, the amphipathic Deg1 region mimicks a signal peptide and is recruited to ...

A fortuitous apposition of cysteine residues in Sec61p and the Deg hybrid permits the formation of a transient disulfide that stabilizes the N terminus of Deg-Sec62 in the ER lumen long enough to make it available for N glycosylation (Fig. 7, A [IV] or B [V]). Of importance to this model is the relative position of cysteine 373 of Sec61p in the crystal structure of the SecY complex (Van den Berg et al., 2004). C373 resides in the cytoplasmic half of TM8 (transmembrane segment eight) with the −SH side chain pointing to the channel interior. Interestingly, the cytoplasmic half of the lateral gate is thought to form at the interface between TM8 and TM2b and between TM2b and TM7. Thus, this residue may contact a retrotranslocating polypeptide chain.

Derlin (yeast Der1p) and Doa10p represent other potential retrotranslocation channels that may act alone or in concert with Sec61p (Wahlman et al., 2007). The task of assigning a direct role for Sec61p in this process is confounded by the effect of sec61 mutations on the translocation process (Pilon et al., 1997; Plemper et al., 1997). Sec61p and Der1p have been assigned roles in the ERAD of the soluble misfolded protein CPY* (Knop et al., 1996; Plemper et al., 1997). However, the role of Sec61p and Der1p in degradation of membrane-bound substrates remains unclear. Der1p, despite being tested against a large panel of membrane-bound ERAD substrates (e.g., Vph1p, Pdr5*, Ste6-6*, CT*, and CTG*; Plemper et al., 1998; Hill and Cooper, 2000; Taxis et al., 2003; Vashist and Ng, 2004), is only known to be partially required for the chimeric ERAD substrate KWW (Vashist and Ng, 2004). Sec61p, although not as extensively tested as Der1p, is required for the degradation of Pdr5* that contains a misfolded luminal domain (Plemper et al., 1998; Walter et al., 2001; Huyer et al., 2004). Sec61-2, which is partially defective in the ERAD of CPY* but not in the ERAD of the Deg-Sec62 hybrid, possesses a mutant residue predicted to face the ER lumen (G213D; Vashist and Ng, 2004). Work from Vashist and Ng (2004) supports a view of multiple ERAD pathways requiring a distinct set of gene products that is dictated by the location of the misfolded domain. Hence, the effect of sec61-2 on the degradation of membrane proteins with luminal misfolded domains and its independence for membrane proteins with cytosolic misfolded domains may result from a lesion in the assembly of the ERAD machinery.

The interaction profiles for the Derlin family of proteins suggest they might act as adaptor proteins to provide a direct link between events on the luminal side of the ER membrane (association with misfolded proteins) with those on the cytoplasmic side (association with the ubiquitin ligase Hrd1 and the p97 AAA-ATPase; Lilley and Ploegh 2005; Ye et al., 2005; Nagasawa et al., 2007). Because Hrd1 and Der1p display overlapping substrate preferences, it is tempting to propose that Der1p organizes the machinery necessary for ubiquitination and extraction of misfolded luminal proteins. In contrast, substrates requiring the Doa10p ubiquitin ligase show Der1p independence because they require other factors for assembly of the degradation machinery. Clearly, much remains to be done to understand exactly how Der1p, Doa10p, and Sec61p participate in the retrotranslocation event.

Materials and methods

Strains and plasmids

All strains used in this study were derived from the strains listed in Table I. Strains that were used to evaluate the functionality of Sec61p mutants were constructed by transformation of RSY633 with Sec61p alleles (CEN/LEU) followed by plasmid selection on 5-FOA plates. These strains were used directly for protein import assays (Fig. 3) or transformed with a CEN/URA plasmid for expression of Deg1:Sec62ProtA to evaluate degradation kinetics in Sec61p mutant backgrounds. To analyze ERAD of CPY* in the Sec61p mutant backgrounds, we created transformants in which the sec61 mutant alleles (CEN/LEU) replaced the wild type. After selection on 5-FOA, these strains were transformed with a CEN/URA plasmid for the expression of CPY* (pHIT341). Pulse-time experiments were performed in the EUROScarf background (BY4742) with strains carrying the indicated chromosomal knockouts (Δubc7) or Deg1:Sec62ProtA variants. For studies to identify the mixed disulfide complex, we generated strains by transformation of YDS174 with the Sec61p-myc alleles (CEN/TRP). After plasmid selection on 5-FOA, these strains were transformed with the ΔCys4:Deg1:Sec62ΔProtA plasmid.

Table I.
Strains used in this study

Plasmids pDF40 (Pilon et al., 1997), pHIT341 (Norgaard et al., 2001), and pSec61-32 (Pilon et al., 1997) have been previously described. A CEN/URA vector for the expression of Deg1:Sec62ProtA was constructed by transfer of an EcoRI–HindIII fragment, containing the Deg1:Sec62ProtA coding region under control of the Gal1-10 promoter, from a yIplac128 (Mayer et al., 1998)-based vector to pRS316. Site-directed mutants of Sec61p and Deg1:Sec62ProtA were constructed using Quick-Change Mutagenesis according to the manufacturer's recommendations (Stratagene) and mutations were confirmed by cycle sequencing. A CEN/LEU-based vector for the expression of sec61-2 was constructed by PCR amplification of RSY524 genomic DNA with the primers 5′ TTGAGCCTGCTGAAAGCTTG 3′ and 5′ AGAAGTTAGCCCGGGACCAT 3′. The resulting fragment was digested with Sma1–HindIII and cloned into pRS315. Additional details of strain construction and cloning are available upon request.


Antisera against ppαf (Wuestehube and Schekman, 1993), Kar2p, and CPY/CPY*(Feldheim et al., 1992) have been previously published. α-Flag M2 (Sigma-Aldrich) and α-myc (clone 9B11; Cell Signaling Technology) monoclonal antibodies were obtained from commercial sources and used according to the manufacturer's recommendations.

Pulse chase and immunoprecipitation

Pulse labeling and immunoprecipitation of ppαf, Kar2p, and CPY to evaluate the translocation activities of the Sec61p alleles were performed as previously described (Feldheim et al., 1992; Doering and Schekman, 1996). For CPY* ERAD, strains expressing CPY* (pHIT341; gift from P. Norgaard, Department of Molecular and Cell Biology and Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA) were grown overnight at 30°C in SCGlc-Ura medium to OD600 = 1.8–2. An aliquot equivalent to 8 ODs was removed and centrifuged and cells were resuspended in 20 ml of fresh SCGlc-Met-Ura. Cells were grown for ∼2 h at 30°C to OD600 = 0.8–0.9. An aliquot equivalent to 8 ODs was removed and centrifuged and cells were resuspended in 3.6 ml of fresh prewarmed SCGlc-Met-Ura medium. After growth at 30°C for 15 min, cultures were labeled with 35S-Translabel (GE Healthcare) at 50 μCi/OD. Chase was initiated by addition of 0.4 ml of a 10× chase solution (SCGlc-Met-Ura containing 0.6% methionine and 0.4% cysteine). At time zero, and the indicated chase times, 1 ml was removed and immediately quenched by the addition of ice-cold sodium azide to 10 mM. Cell lysis and immunoprecipitation of CPY* was performed by methods described for CPY (beginning of paragraph).

Strains expressing Deg1:Sec62ProtA for degradation assays were grown overnight at 30°C in SCRaf-Ura medium. Cells were then subcultured into SCGal-Met-Ura medium at OD600 = 0.05 and grown at 30°C to OD600 = 0.9–1. An aliquot equivalent to 12 ODs was centrifuged, and cells were resuspended in fresh prewarmed SCGal-Met-Ura medium and allowed to grow at 30°C for 15 min. Labeling was initiated by the addition of 35S-Translabel at 50 μCi/OD. After 5 min, 0.4 ml of a 10× chase solution was added. At time zero and the indicated chase times, 1 ml was removed and immediately quenched by the addition of ice-cold sodium azide to 10 mM. Cell lysis and immunoprecipitation of Deg1:Sec62ProtA with IgG Sepharose beads was performed as previously described (Biederer et al., 1996). In brief, cell pellets were thawed and resuspended in 110 μl of ice-cold buffer A (50 mM Tris-Cl, pH 7.4, 10 mM EDTA, and Complete Mini EDTA-free protease inhibitors [Roche]). Cell disruption was performed with 1 vol of glass beads by four cycles of vortex mixing for 30 s, interrupted by 30-s incubation on ice. The lysate was next diluted to 900 μl with ice-cold buffer A and cleared by low-speed centrifugation at 1,000 g. Membranes were isolated from the supernatant by centrifugation at 16,000 g for 10 min, resuspended in 100 μl buffer B (50 mM Tris-Cl, pH 7.5, and 150 mM NaCl), and diluted to a final volume of 900 μl in buffer C (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 11.3 mM EDTA, 1.1% Triton X-100, 0.11% SDS, and complete protease inhibitors). IgG Sepharose (100 μl of a 20% slurry in buffer C) was added and the mixtures were incubated with rotation at 4°C for 2–4 h. Beads were collected, washed three times with 900 μl of buffer C, and resuspended in 50 μl 2X sample buffer. Samples were heated at 55°C for 10 min and proteins were separated on 9.5% SDS-PAGE. After drying, the gels were exposed to a phosphoimager cassette for detection and quantitation. Degradation kinetics are expressed as the sum of decay for the two substrate species over time. Although the degradation rates for glycosylated and unglycosylated substrate are different, we chose to express decay in this manner because the glycosylation site mutant, N153D, is degraded at a rate identical to the sum of the two wild-type substrate species (Fig. 2, D and E).

Labeling and immunoprecipitation of Deg1:Sec62ProtA for pulse-time experiments (Fig. 5) was performed as described for pulse-chase experiments (previous paragraph), with the only difference being the time cells were exposed to radiolabel. Cells were quenched at the indicated pulse time (i.e., 2, 4, 6, or 8 min) by the addition of sodium azide to 10 mM. Data are presented as the ratio of glycosylated to unglycosylated forms of the substrate protein at each labeling time.

Endoglycosidase H treatment

Steady-state levels of Deg1:Sec62ProtA were immunoprecipitated from wild-type cells as described for the pulse-chase experiments (Pulse chase and immunoprecipitation). Bound protein was eluted from the IgG Sepharose beads by heating in 1% SDS/50 mM Tris, pH 7.4. The eluted sample was diluted 20-fold into a final buffer concentration of 50 mM sodium citrate, pH 5.5. Samples were aliquoted into separate tubes and mock treated or treated with 1 mU of endoglycosidase-H (Boehringer Ingelheim). Mixtures were incubated for 3 h at 37°C and stopped by the addition of 2× sample buffer. Proteins were resolved by electrophoresis on 9.5% SDS-PAGE gels, transferred to nitrocellulose membranes, and developed with anti-Flag M2 monoclonal antibodies.

Microsomal membrane isolation and protease protection

Yeast cells expressing Deg1:Sec62ProtA were grown in SD-Ura 2% raffionose, 0.1% glucose overnight at 30°C. Cells were diluted to 0.05 OD600/ml in SD-Ura 2% galactose and grown at 30°C for 8 h to induce expression of the hybrid. Cells (OD600 = 15) were harvested and resuspended in 1 ml of 10-mM Tris-HCl, pH 9.4, containing 10 mM dithiothreitol and incubated at room temperature for 10 min. Cells were collected by centrifugation and washed with spheroplast buffer (1 M sorbitol, 20 mM sodium phosphate, pH 7.5, 150 mM NaCl, and 2 mM dithiothreitol). Cells were recollected and resuspended in 1 ml of spheroplast buffer. Cell walls were digested with 140 μg zymolase 100T (Seikagu Corporation)/10 OD600 equivalents for 20 min at 30°C. Spheroplasts were centrifuged (5 min at 600 g at 4°C) and washed in prechilled spheroplast buffer containing 20 μg/ml pepstatin and 1 mM EDTA, pH 8. Cells were centrifuged again and resuspended in 1 ml of fractionation buffer (200 mM d-mannitol, 20 mM sodium phosphate, pH 7.5, and 150 mM NaCl) containing 20 μg/ml pepstatin and 1 mM EDTA, pH 8. Lysis was achieved by the addition of 300 μl of acid-washed glass beads (Sigma-Aldrich) and 1 min of agitation with a vortex mixer at 4°C. Unlysed cells and cell debris were centrifuged for 5 min at 600 g at 4°C. Crude microsomal fractions were collected by centrifugation and resuspended in buffer (50 mM Tris, pH 7.4, and 200 mM NaCl) at ∼0.5 OD600 equivalents/ml. The microsome fraction was split into three aliquots (∼4 OD600 equivalents each). One was mock treated with buffer and the others were digested with 5 μg/ml trypsin in the absence or presence of 1% Triton X-100 for 30 min on ice. Digestions were stopped by the addition of trichloroacetic acid to 15%. After a 30-min incubation on ice, precipitated material was collected by centrifugation and washed once with ice-cold acetone. Pellets were resuspended in 50 μl SDS-PAGE sample buffer, heated at 55°C for 15 min, and subjected to electrophoresis. Proteins were transferred to nitrocellulose and subjected to immunoblotting with anti-Kar2 (microsomal integrity control), anti–Protein A (C terminus of hybrid), or anti-Flag (N terminus of hybrid) antibodies.

Two-dimensional nonreducing/reducing SDS-PAGE

Cells expressing ΔCys4:Deg1:Sec62ΔProtA or Δ13-32:ΔCys4:Deg1:Sec62ΔProtA (Fig. S2) were grown and membranes were isolated from the cell pellets as described for the pulse-chase experiments (Pulse chase and immunoprecipitation). Membrane pellets were then resuspended in 4× SDS-PAGE sample buffer without reducing agent to a concentration approximately corresponding to 0.4 OD600 equivalents/μl (for substrate blots) or 1.5 OD600 equivalents/μl (for Sec61p blots). After 10 min at 55°C, 60 μl of the sample was electrophoresed on 9.5% SDS-PAGE gels. After electrophoresis in the first dimension, the lane was excised with a razorblade and soaked in 5 ml of sample buffer containing 10% β-mercaptoethanol at 90°C for 5 min. The gel sliver was then placed on top of a second 9.5% SDS-PAGE trough gel and electrophoresed in the second dimension. After transfer to nitrocellulose, but before detection with anti-flag or anti-myc antibodies, the membrane was stained with Ponceau S to demarcate the protein diagonal band. Blots were developed with ECL Plus (GE Healthcare) and scanned with a typhoon imager for quantitation. To compare the relative amounts of Sec61p and Deg1:Sec62ProtA between the strain backgrounds, we sampled serial dilutions of the membrane suspension under reducing conditions and quantified the resulting protein species. In all experiments, there was a <5–10% difference in the total amount of Sec61p or Deg1:Sec62ProtA applied to the two-dimensional gels.

Online supplemental material

Fig. S1 shows the protease susceptibility of Deg1:Sec62ProtA. Fig. S2 shows the two-dimensional nonreducing/reducing SDS-PAGE analysis of the deg1 determinant deletion mutant Δ13–32:ΔCys4:Deg1:Sec62ΔProtA. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200804053/DC1.

Supplementary Material

[Supplemental Material Index]


D.C. Scott's current address is Depts. of Structural Biology and Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.

Abbreviations used in this paper: αf, α-factor; CPY, carboxypeptidase Y; ERAD, ER-associated degradation.


  • Biederer, T., C. Volkwein, and T. Sommer. 1996. Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway. EMBO J. 15:2069–2076. [PMC free article] [PubMed]
  • Brachmann, C.B., A. Davies, G.J. Cost, E. Caputo, J. Li, P. Hieter, and J.D. Boeke. 1998. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast. 14:115–132. [PubMed]
  • Brodsky, J.L., and A.A. McCracken. 1999. ER protein quality control and proteasome-mediated degradation. Semin. Cell Dev. Biol. 10:507–513. [PubMed]
  • Deshaies, R.J., and R. Schekman. 1989. SEC62 encodes a putative membrane protein required for protein translocation into the yeast endoplasmic reticulum. J. Cell Biol. 109:2653–2664. [PMC free article] [PubMed]
  • Doering, T.L., and R. Schekman. 1996. GPI anchor attachment is required for Gas1p transport from the endoplasmic reticulum in COP II vesicles. EMBO J. 15:182–191. [PMC free article] [PubMed]
  • Ellgaard, L., and A. Helenius. 2003. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4:181–191. [PubMed]
  • Feldheim, D., J. Rothbatt, and R. Schekman. 1992. Topology and functional domains of Sec63p, an endoplasmic reticulum membrane protein required for secretory protein translocation. Mol. Cell. Biol. 12:3288–3296. [PMC free article] [PubMed]
  • Finger, A., M. Knop, and D.H. Wolf. 1993. Analysis of two mutated vacuolar proteins reveals a degradation pathway in the endoplasmic reticulum or a related compartment of yeast. Eur. J. Biochem. 218:565–574. [PubMed]
  • Flierman, D., Y. Ye, M. Dai, V. Chau, and T.A. Rapoport. 2003. Polyubiquitin serves as a recognition signal, rather than a ratcheting molecule, during retrotranslocation of proteins across the endoplasmic reticulum membrane. J. Biol. Chem. 278:34774–34782. [PubMed]
  • Hampton, R.Y. 2002. ER-associated degradation in protein quality control and cellular regulation. Curr. Opin. Cell Biol. 14:476–482. [PubMed]
  • Hill, K., and A.A. Cooper. 2000. Degradation of unassembled Vph1p reveals novel aspects of the yeast ER quality control system. EMBO J. 19:550–561. [PMC free article] [PubMed]
  • Hitt, R., and D.H. Wolf. 2004. Der1p, a protein required for degradation of malfolded soluble proteins of the endoplasmic reticulum: topology and Der1-like proteins. FEMS Yeast Res. 4:721–729. [PubMed]
  • Ho, C.Y., M. Smith, M.E. Houston, J.G. Adamson, and R.S. Hodges. 2002. A possible mechanism for partitioning between homo- and heterodimerization of the yeast homeodomain proteins MATa1 and MATalpha2. J. Pept. Res. 59:34–43. [PubMed]
  • Huyer, G., W.F. Piluek, Z. Fansler, S.G. Kreft, M. Hochstrasser, J.L. Brodsky, and S. Michaelis. 2004. Distinct machinery is required in Saccharomyces cerevisiae for the endoplasmic reticulum-associated degradation of a multispanning membrane protein and a soluble luminal protein. J. Biol. Chem. 279:38369–38378. [PubMed]
  • Jackson, D.D., and T.H. Stevens. 1997. VMA12 encodes a yeast endoplasmic reticulum protein required for vacuolar H+-ATPase assembly. J. Biol. Chem. 272:25928–25934. [PubMed]
  • Jakob, C.A., D. Bodmer, U. Spiring, P. Battig, A. Marcil, D. Dignard, J.J. Bergeron, D.Y. Thomas, and M. Aeb. 2001. Htm1p, a mannosidase-like protein, is involved in glycoprotein degradation in yeast. EMBO Rep. 2:423–430. [PMC free article] [PubMed]
  • Jensen, T.J., M.A. Loo, S. Pind, D.B. Williams, A.L. Goldberg, and J.R. Riodan. 1995. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 83:129–135. [PubMed]
  • Johnson, P.R., R. Swanson, L. Rakhilina, and M. Hochstrasser. 1998. Degradation signal masking by heterodimerization of MATalpha2 and MATa1 blocks their mutual destruction by the ubiquitin-proteasome pathway. Cell. 94:217–227. [PubMed]
  • Kim, I., J. Ahn, C. Liu, K. Tanabe, J. Apodaca, T. Suzuki, and H. Rao. 2006. The Png1–Rad23 complex regulates glycoprotein turnover. J. Cell Biol. 172:211–219. [PMC free article] [PubMed]
  • Kim, W., E.D. Spear, and D.T. Ng. 2005. Yos9p detects and targets glycoproteins for ER-associated degradation. Mol. Cell. 19:753–764. [PubMed]
  • Knop, M., A. Finger, T. Braun, K. Hellmuth, and D.H. Wolf. 1996. Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO J. 15:753–763. [PMC free article] [PubMed]
  • Kreft, S.G., L. Wang, and M. Hochstrasser. 2006. Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI). J. Biol. Chem. 281:4646–4653. [PubMed]
  • Lilley, B.N., and H.L. Ploegh. 2004. A membrane protein required for dislocation of misfolded proteins from the ER. Nature. 429:834–840. [PubMed]
  • Lilley, B.N., and H.L. Ploegh. 2005. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. USA. 102:14296–14301. [PMC free article] [PubMed]
  • Liu, Y., P. Choudhury, C.M. Cabral, and R.N. Sifers. 1999. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J. Biol. Chem. 274:5861–5867. [PubMed]
  • Mayer, T.U., T. Braun, and S. Jentsch. 1998. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J. 17:3251–3257. [PMC free article] [PubMed]
  • Nagasawa, K., T. Higashi, N. Hosokawa, R.J. Kaufman, and K. Nagata. 2007. Simultaneous induction of the four subunits of the TRAP complex by ER stress accelerates ER degradation. EMBO Rep. 8:483–489. [PMC free article] [PubMed]
  • Norgaard, P., W. Vibeke, C. Tachibana, L. Alsoe, B. Holst, and J.R. Winther. 2001. Functional differences in yeast protein disulfide isomerases. J. Cell Biol. 152:553–562. [PMC free article] [PubMed]
  • Ng, W., T. Sergeyenko, N. Zeng, J.D. Brown, and K. Romisch. 2007. Characterization of the proteasome interaction with the Sec61 channel in the endoplasmic reticulum. J. Cell Sci. 120:682–691. [PubMed]
  • Oyadomari, S., C. Yun, E. Fisher, N. Kreglinger, G. Kreibich, M. Oyadomari, H.P. Harding, A.G. Goodman, H. Harant, J.L. Garrison, et al. 2006. Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell. 126:727–739. [PubMed]
  • Pilon, M., R. Schekman, and K. Romisch. 1997. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J. 16:4540–4548. [PMC free article] [PubMed]
  • Pilon, M., K. Romisch, D. Quach, and R. Schekman. 1998. Sec61p serves multiple roles in secretory precursor binding and translocation into the endoplasmic reticulum membrane. Mol. Biol. Cell. 9:3455–3473. [PMC free article] [PubMed]
  • Plemper, R.K., S. Bohmler, J. Bordallo, T. Sommer, and D.H. Wolf. 1997. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature. 388:891–895. [PubMed]
  • Plemper, R.K., R. Egner, K. Kuchler, and D.H. Wolf. 1998. Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome. J. Biol. Chem. 273:32848–32856. [PubMed]
  • Ravid, T., S.G. Kreft, and M. Hochstrasser. 2006. Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways. EMBO J. 25:533–543. [PMC free article] [PubMed]
  • Schmitz, A., H. Herrgen, A. Winkeler, and V. Herzog. 2000. Cholera toxin is exported from microsomes by the Sec61 complex. J. Cell Biol. 148:1203–1212. [PMC free article] [PubMed]
  • Spear, E.D., and D.T. Ng. 2005. Single, context-specific glycans can target misfolded glycoproteins for ER-associated degradation. J. Cell Biol. 169:73–82. [PMC free article] [PubMed]
  • Swanson, R., M. Locher, and M. Hochstrasser. 2001. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation. Genes Dev. 15:2660–2674. [PMC free article] [PubMed]
  • Taxis, C., R. Hitt, S. Park, P.M. Deak, Z. Kostova, and D.H. Wolf. 2003. Use of modular substrates demonstrates mechanistic diversity and reveals differences in chaperone requirement of ERAD. J. Biol. Chem. 278:35903–35913. [PubMed]
  • Tirosh, B., M.H. Furman, D. Tortorella, and H.L. Ploegh. 2003. Protein unfolding is not a prerequisite for endoplasmic reticulum-to-cytosol dislocation. J. Biol. Chem. 278:6664–6672. [PubMed]
  • Van den Berg, B., W.M. Clemons, I. Collinson, Y. Modis, E. Hartmann, S.C. Harrison, and T.A. Rapoport. 2004. X-ray structure of a protein-conducting channel. Nature. 427:36–44. [PubMed]
  • Vashist, S., and D.T. Ng. 2004. Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J. Cell Biol. 165:41–52. [PMC free article] [PubMed]
  • Wahlman, J., G.N. DeMartino, W.R. Skach, N.J. Bulleid, J.L. Brodsky, and A.E. Johnson. 2007. Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system. Cell. 129:943–955. [PMC free article] [PubMed]
  • Walter, J., J. Urban, C. Volkwein, and T. Sommer. 2001. Sec61p-independent degradation of the tail-anchored membrane protein Ubc6p. EMBO J. 20:3124–3131. [PMC free article] [PubMed]
  • Ward, C.L., S. Omura, and R.R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 83:121–127. [PubMed]
  • Wiertz, E.J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones, T.A. Rapoport, and H.L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384:432–438. [PubMed]
  • Wuestehube, L.J., and R. Schekman. 1993. Selection and screening for yeast secretory mutants. Methods in Molecular Genetics. 1:88–106.
  • Ye, Y., Y. Shibata, C. Yun, D. Ron, and T.A. Rapoport. 2004. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature. 429:841–847. [PubMed]
  • Ye, Y., Y. Shibata, M. Kikkert, S. van Voorden, E. Wiertz, and T.A. Rapoport. 2005. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. USA. 102:14132–14138. [PMC free article] [PubMed]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
  • Gene
    Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
  • GEO Profiles
    GEO Profiles
    Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
  • HomoloGene
    HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...